AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bayer, A. S.
Right arrow Articles by Yeaman, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bayer, A. S.
Right arrow Articles by Yeaman, M. R.
Antimicrobial Agents and Chemotherapy, July 2006, p. 2448-2454, Vol. 50, No. 7
0066-4804/06/$08.00+0     doi:10.1128/AAC.00028-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Low-Level Resistance of Staphylococcus aureus to Thrombin-Induced Platelet Microbicidal Protein 1 In Vitro Associated with qacA Gene Carriage Is Independent of Multidrug Efflux Pump Activity

A. S. Bayer,1,2* L. I. Kupferwasser,1,{dagger} M. H. Brown,3 R. A. Skurray,3 S. Grkovic,3,{ddagger} T. Jones,1 K. Mukhopadhay,1 and M. R. Yeaman1,2

Division of Infectious Diseases, Harbor-UCLA Medical Center, Torrance, California, and LA Biomedical Research Institute at Harbor-UCLA, Torrance, California,1 Geffen School of Medicine at UCLA, Los Angeles, California,2 School of Biological Sciences, The University of Sydney, Sydney, New South Wales 2006, Australia3

Received 8 January 2006/ Returned for modification 13 February 2006/ Accepted 12 April 2006

Thrombin-induced platelet microbial protein 1 (tPMP-1), a cationic antimicrobial polypeptide released from thrombin-stimulated rabbit platelets, targets the Staphylococcus aureus cytoplasmic membrane to initiate its microbicidal effects. In vitro resistance to tPMP-1 correlates with survival advantages in vivo. In S. aureus, the plasmid-carried qacA gene encodes a multidrug transporter, conferring resistance to organic cations (e.g., ethidium [Et]) via proton motive force (PMF)-energized export. We previously showed that qacA also confers a tPMP-1-resistant (tPMP-1r) phenotype in vitro. The current study evaluated whether (i) transporters encoded by the qacB and qacC multidrug resistance genes also confer tPMP-1r and (ii) tPMP-1r mediated by qacA is dependent on efflux pump activity. In contrast to tPMP-1r qacA-bearing strains, the parental strain and its isogenic qacB- and qacC-containing strains were tPMP-1 susceptible (tPMP-1s). Efflux pump inhibition by cyanide m-chlorophenylhydrazone abrogated Etr, but not tPMP-1r, in the qacA-bearing strain. In synergy assays, exposure of the qacA-bearing strain to tPMP-1 did not affect the susceptibility of Et (ruling out Et-tPMP-1 cotransport). The following cytoplasmic membrane parameters did not differ significantly between the qacA-bearing and parental strains: contents of the major phospholipids; asymmetric distributions of the positively charged species, lysyl-phosphotidylglycerol; fatty acid composition; and relative surface charge. Of note, the qacA-bearing strain exhibited greater membrane fluidity than that of the parental, qacB-, or qacC-bearing strain. In conclusion, among these families of efflux pumps, only the multidrug transporter encoded by qacA conferred a tPMP-1r phenotype. These data suggest that qacA-encoded tPMP-1r results from the impact of a specific transporter upon membrane structure or function unrelated to PMF-dependent peptide efflux.


* Corresponding author. Mailing address: Division of Infectious Diseases, c/o LA Biomedical Research Institute, 1124 W. Carson St., Building RB2, Room 225, Torrance, CA. Phone: (310) 222-6422. Fax: (310) 782-2016. E-mail: bayer{at}humc.edu.

{dagger} Current address: Division of Cardiology, Cedars-Sinai Medical Center, Los Angeles, CA.

{ddagger} Current address: Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, NSW, Australia.


Antimicrobial Agents and Chemotherapy, July 2006, p. 2448-2454, Vol. 50, No. 7
0066-4804/06/$08.00+0     doi:10.1128/AAC.00028-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.